1 / 22

Brian C. Springer, MHA Executive Director Siteman Cancer Center Barnes-Jewish Hospital & Washington U. School of Med

CCSG-CTSA Interactions. Michael Bertram, PhD, MBA Associate Director for Administration UAB Comprehensive Cancer Center. Kara Newton Administrative Director UAB Center for Clinical & Translational Science. Brian C. Springer, MHA Executive Director Siteman Cancer Center

quynh
Télécharger la présentation

Brian C. Springer, MHA Executive Director Siteman Cancer Center Barnes-Jewish Hospital & Washington U. School of Med

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CCSG-CTSA Interactions Michael Bertram, PhD, MBA Associate Director for Administration UAB Comprehensive Cancer Center Kara Newton Administrative Director UAB Center for Clinical & Translational Science Brian C. Springer, MHA Executive Director Siteman Cancer Center Barnes-Jewish Hospital & Washington U. School of Med

  2. Overview • We encourage discussion along the way … Overview of CTSAs Development of the Applications Collaborative Culture Relationship at the Site Visit Future Directions

  3. Overview of CTSAs Strategic Goals Across the Consortium National Clinical and Translational Research Capability The Training and Career Development of Clinical and Translational Scientists Consortium-Wide Collaborations The Health of our Communities and the Nation T1 Translational Research

  4. Overview of CTSAs

  5. Overview of CTSAs • Each CTSA institution has created a home for clinical and translational science. • Input from the NIH and other federal agencies, industry, and private and community organizations helps guide the work of every CTSA institution.

  6. Our Respective CTSAs • THE UNIVERSITY OF • ALABAMA AT BIRMINGHAM • Center for Clinical and Translational Science • Funded in 2007 • 8 Collaborating Institutions • 5 Clinical Research Cores • 12 Other Research Cores • 2 Research Education Programs • 4 Community Engagement Programs • Funded in 2008 • Unique Drug Discovery Component • Novel Collaborations with Southern Research Institute & HudsonAlpha Institute for Biotechnology • 9 Research Cores • 2 Research Education Programs • Dual Community Engagement Program • One Great Community & • Deep South Network

  7. … Briefly, Application Development … • Council for Center Directors • Council for Translational Research (CCC Represented) • CCTS Biomedical Informatics Synergized Institutional efforts: CCC, UAB Health System, UAB IT • Catalyzed the establishment of a Division of Biomedical Informatics • Council of Centers • Council of Administrators • Broad collaboration in all areas between ICTS and SCC • Leveraging of programs and relationships … • … and infrastructure and grant materials

  8. Collaborative Culture • Shared Leadership Advisory Boards & Executive Committees, Core Directors, Deep South Networks, Council for Translational Research& Working Groups • Broad Institutional Initiatives Informatics, caBIG, Clinical Data Warehouse, Drug Discovery Program, Clinical Research Operations, SOM Strategic Planning, VA Research Activities • Leveraging Stakeholders’ Investments

  9. Collaborative Culture • Strong Institutional Investment • Shared Leaders (ICTS/SCC) • New Seminar Series • Monthly Management Meetings (ICTS/SCC) • Best Practices (membership, citations, EAB) • Joint Project • Ability to Represent Joint Interests

  10. Shared Resources ICTS 28 shared resources SCC 14 shared resources 5 shared cores + 1 developmental Biostatistics, Biomedical Informatics, Human Imaging (IRAT/HIU), Proteomics, Tissue, Plus Developmental (HAMLET)

  11. Subsidy for Siteman members Subsidy for ICTS members Shared Resources Philosophy behind multiple subsidies: For two years, shared electronic user survey for all ICTS and SCC shared resources.

  12. Transformative Partnerships Academic Drug Discovery and Development at UAB & SRI: Molecular Library High through-put screening 3D structure of targets Medicinal chemistry with in silicoscreening Preclinical toxicology and ADME analysis

  13. Pilot Projects FY11 over $1 million in co-sponsored projects FY11 over $120,000 in CTSA partnerships and $150,000 in Drug Discovery Alliance projects from UAB CCC • CCTS/University-wide Centers match program • CCC/CCTS Drug Discovery Projects Nascent Projects Panel (shared mentorship) Streamlined online application & review process

  14. Pilot Projects • Robust BJHF-ICTS Funding Program (> $1 million/year) • Many SCC Pilot Programs (2011 > $1 million) • Sharing credit for each others’ successes

  15. Information Resources Publications – joint input Web resources Shared resource listings

  16. Information Resources University-Wide Center Listserv For Announcements & Opportunities CCC Monthly e-Newsletter, Quarterly Magazine, Facebook CCTS Weekly e-Digest, Quarterly Newsletter, Twitter

  17. Institutional Impact • Key Components of SOM Strategic Planning • Cancer 1 of 6 priority research themes • CCTS 1 of 5 cross-disciplinary platforms • Catalyze Research Center Interactions • Representation for Campus-wide Systems • Integrated Information Systems • Shared Facility Coordination • Phase I Clinical Trials Unit Priority • Enterprise Wide Adoption caBIG CTMS • Together, We Are Stronger

  18. Institutional Impact SCC as a trailblazer Strength of both centers in partnership to foster institutional change Increased grant funding More collaborative culture

  19. Best Practices? So what have you tried that has worked???

  20. Site Visits • CCTS Director participated in CCC Site Visit highlighting collaborations during the Director’s overview

  21. Future Directions • Greater consolidation • Greater leverages • CTSA transition to new NIH Institute targeted for October 2011 • National Center for Advancing Translational Sciences (NCATS) • Emphasis on T1 research • New and more effective therapeutics • New NIH-FDA partnership activities

  22. Last Thoughts

More Related